Alicia Secor - Net Worth and Insider Trading

Alicia Secor Net Worth

The estimated net worth of Alicia Secor is at least $4 Million dollars as of 2024-11-05. Alicia Secor is the Director of GW Pharmaceuticals PLC and owns about 16,440 shares of GW Pharmaceuticals PLC (GWPH) stock worth over $4 Million. Alicia Secor is the President and CEO of Juniper Pharmaceuticals Inc and owns about 5,000 shares of Juniper Pharmaceuticals Inc (JNP) stock worth over $57,500. Alicia Secor is also the Chief Commercial Officer of Zafgen Inc and owns about 333 shares of Zafgen Inc (ZFGN) stock worth over $330. Details can be seen in Alicia Secor's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alicia Secor has not made any transactions after 2020-03-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Alicia Secor

To

Alicia Secor Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alicia Secor owns 5 companies in total, including Orchard Therapeutics PLC (ORTX) , GW Pharmaceuticals PLC (GWPH) , and Juniper Pharmaceuticals Inc (JNP) among others .

Click here to see the complete history of Alicia Secor’s form 4 insider trades.

Insider Ownership Summary of Alicia Secor

Ticker Comapny Transaction Date Type of Owner
ORTX Orchard Therapeutics PLC 2020-01-01 director
GWPH GW Pharmaceuticals PLC 2020-06-04 director
JNP Juniper Pharmaceuticals Inc 2018-08-14 director & President and CEO
LIMIT LIMIT 2015-09-17 Chief Commercial Officer
LIMIT LIMIT 2021-06-17 director

Alicia Secor Latest Holdings Summary

Alicia Secor currently owns a total of 3 stocks. Among these stocks, Alicia Secor owns 16,440 shares of GW Pharmaceuticals PLC (GWPH) as of March 2, 2020, with a value of $4 Million and a weighting of 98.42%. Alicia Secor owns 5,000 shares of Juniper Pharmaceuticals Inc (JNP) as of August 25, 2016, with a value of $57,500 and a weighting of 1.57%. Alicia Secor also owns 333 shares of Zafgen Inc (ZFGN) as of September 17, 2015, with a value of $330 and a weighting of 0.01%.

Latest Holdings of Alicia Secor

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GWPH GW Pharmaceuticals PLC 2020-03-02 16,440 218.96 3,599,702
JNP Juniper Pharmaceuticals Inc 2016-08-25 5,000 11.50 57,500
ZFGN Zafgen Inc 2015-09-17 333 0.99 330

Holding Weightings of Alicia Secor


Alicia Secor Form 4 Trading Tracker

According to the SEC Form 4 filings, Alicia Secor has made a total of 2 transactions in GW Pharmaceuticals PLC (GWPH) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in GW Pharmaceuticals PLC is the sale of 1,296 shares on March 2, 2020, which brought Alicia Secor around $10,809.

According to the SEC Form 4 filings, Alicia Secor has made a total of 0 transactions in Juniper Pharmaceuticals Inc (JNP) over the past 5 years. The most-recent trade in Juniper Pharmaceuticals Inc is the acquisition of 5,000 shares on August 25, 2016, which cost Alicia Secor around $28,750.

According to the SEC Form 4 filings, Alicia Secor has made a total of 0 transactions in Zafgen Inc (ZFGN) over the past 5 years. The most-recent trade in Zafgen Inc is the sale of 2,188 shares on September 17, 2015, which brought Alicia Secor around $1 Million.

Insider Trading History of Alicia Secor

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alicia Secor Trading Performance

GuruFocus tracks the stock performance after each of Alicia Secor's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alicia Secor is -0.88%. GuruFocus also compares Alicia Secor's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alicia Secor within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Alicia Secor's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Alicia Secor

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.67 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 7.03 LIMIT LIMIT LIMIT LIMIT LIMIT

Alicia Secor Ownership Network

Ownership Network List of Alicia Secor

No Data

Ownership Network Relation of Alicia Secor

Insider Network Chart

Alicia Secor Owned Company Details

What does Orchard Therapeutics PLC do?

Who are the key executives at Orchard Therapeutics PLC?

Alicia Secor is the director of Orchard Therapeutics PLC. Other key executives at Orchard Therapeutics PLC include director & See Remarks Bobby Gaspar , 10 percent owner & other: See Remark 1 Fmr Llc , and 10 percent owner Ra Capital Healthcare Fund Lp .

Orchard Therapeutics PLC (ORTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Orchard Therapeutics PLC (ORTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Orchard Therapeutics PLC (ORTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Orchard Therapeutics PLC (ORTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Orchard Therapeutics PLC Insider Transactions

No Available Data

Alicia Secor Mailing Address

Above is the net worth, insider trading, and ownership report for Alicia Secor. You might contact Alicia Secor via mailing address: 33 Hayden Ave., Lexington Ma 02421.